Estrella Immunopharma, Inc.

Company name

Website

Start date

End date

Ticker

Listed market

NASDAQ

Country

United States of America

Business activities

Develops T-cell therapies for cancer treatment.

Advances CD19 and CD22 targeting chimeric antigen receptor T-cell therapies.

Head office

5858 Horton Street, Suite 370, Emeryville, CA 94608, United States

Chief executive

Cheng Liu

Employees (non-consolidated)

Employees (consolidated)

Related companies

Company name

Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder

Relationship graph

News

+ Loaded when opened

Data sources

News pages

Own domain

✅

Last updated

2026-09-21 18:15 (Model: )